Hyperthyroidism
American Thyroid AssociationPublished: November 28, 2016
- Key Points
- Diagnostic Recommendations
- Determination of Etiology
- Symptomatic Management
- Risk Factors for Graves’ Orbitopathy
- Algorithm: A Suggested Approach to the Management of Amiodarone-induced Thyrotoxicosis
- Treatment Recommendations
- Graves’ Disease
- Medical Treatment
- Thyroidectomy
- Thyroid Nodules in Graves’ Disease
- Thyroid Storm
- Graves Disease with Orbitopathy
- Graves’ Disease
- Children and Adolescents
- Toxic Multinodular Goiter and Toxic Adenoma
- Clinical Situations That Favor a Particular Modality as Treatment
- Subclinical Hyperthyroidism
- Pregnancy
- Drug-Associated Thyrotoxicosis
- Destructive Thyroiditis
- Tables
- Causes of Thyrotoxicosis
- Beta-Adrenergic Receptor Blockade in the Treatment of Thyrotoxicosis
- Clinical Situations That Favor a Particular Modality as Treatment for Graves’ Hyperthyroidism
- Point Scale for the Diagnosis of Thyroid Storm
- Thyroid Storm: Drugs and Doses
- Assessment of Graves’ Orbitopathy: Clinical Activity Score Elements
- Graves’ Orbitopathy Severity Assessment
- Subclinical Hyperthyroidism: When to Treat
- Causes of Drug-Associated Thyrotoxicosis
- Unusual Causes of Thyrotoxicosis
- Theoretical Projections of Cancer Incidence or Cancer Mortality Related to 131I Therapy for Hyperthyroidism as Related to Age
Also Found In
You rely on Guideline Central for transparency
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.